RAPT Therapeutics
Stock Forecast, Prediction & Price Target

RAPT Therapeutics (RAPT) stock Price Target by analysts

Last Year
Average Price Target

$2

Potential downside: -81.27%

Based on 2 analysts

RAPT Therapeutics price prediction

Strike.market

What is RAPT Therapeutics stock analysts` prediction?

RAPT Therapeutics stock forecast: Based on 2 Wall Street analysts` predicted price targets for RAPT Therapeutics in the last 3 months, the avarage price target is $2, with a high forecast of $NaN. The average price target represents a -81.27% change from the last price of $10.68.

Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.

RAPT Therapeutics stock Price Target by analysts

Full breakdown of analysts given RAPT Therapeutics price targets

Analyst name & company
Analyst win rate
Publish date
Price target
Price when posted
Source Historical targets
Alex Thompson
Stifel Nicolaus
0%
0/1
10 months ago $2 -81.27% downside $1.74 StreetInsider
Previous targets (0)
Thomas Smith
Leerink Partners
0%
0/1
10 months ago $2 -81.27% downside $1.74 StreetInsider
Previous targets (0)
Unknown
Guggenheim
N/A
over 2 years ago $55 414.98% upside $19.83 Benzinga
N/A
Unknown
Wells Fargo
N/A
over 2 years ago $48 349.43% upside $19.5 Benzinga
N/A
Edward Tenthoff
Piper Sandler
0%
0/1
over 2 years ago $33 208.98% upside $16.48 TheFly
Previous targets (0)
Unknown
Goldman Sachs
N/A
almost 3 years ago $27 152.80% upside $17.68 Benzinga
N/A
Unknown
Piper Sandler
N/A
almost 3 years ago $34 218.35% upside $21.98 Benzinga
N/A
Zegbeh Jallah
Capital One Financial
0%
0/1
almost 3 years ago $48 349.43% upside $24.17 TheFly
Previous targets (0)

RAPT Therapeutics Financial Estimates

RAPT Therapeutics Revenue Estimates

RAPT Therapeutics EBITDA Estimates

RAPT Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$3.81M
 
N/A
$1.52M
 
-59.95%
$0
 
-100%
Avg: $768.35K
Low: $768.35K
High: $768.35K
avg. 0%
Avg: $16.43M
Low: $16.43M
High: $16.43M
avg. 2038.78%
Avg: $202.5M
Low: $202.5M
High: $202.5M
avg. 1132.25%
Avg: $311.6M
Low: $311.6M
High: $311.6M
avg. 53.87%
Net Income
 
% change YoY
$-68.20M
 
N/A
$-81.88M
 
-20.04%
$-116.79M
 
-42.64%
Avg: $-132.05M
Low: $-190.15M
High: $-41.40M
avg. -13.06%
Avg: $-234.86M
Low: $-268.75M
High: $-63.65M
avg. -77.84%
Avg: $-18.01M
Low: $-18.01M
High: $-18.01M
avg. 92.32%
Avg: $38.33M
Low: $38.33M
High: $38.33M
avg. 312.76%
EBITDA
 
% change YoY
$-69.20M
 
N/A
$-85.79M
 
-23.96%
$-125.84M
 
-46.68%
Avg: $-153.66K
Low: $-153.66K
High: $-153.66K
avg. 99.87%
Avg: $-3.28M
Low: $-3.28M
High: $-3.28M
avg. -2038.79%
Avg: $-40.49M
Low: $-40.49M
High: $-40.49M
avg. -1132.25%
Avg: $-62.31M
Low: $-62.31M
High: $-62.31M
avg. -53.87%
EPS
 
% change YoY
-$2.49
 
N/A
-$2.52
 
-1.20%
-$3.05
 
-21.03%
Avg: -$2.64
Low: -$4.96
High: -$1.08
avg. 13.54%
Avg: -$3.73
Low: -$7.01
High: -$1.66
avg. -41.36%
Avg: -$0.47
Low: -$0.47
High: -$0.47
avg. 87.39%
Avg: $1
Low: $1
High: $1
avg. 312.76%
Operating Expenses
 
% change YoY
$73.02M
 
N/A
$87.32M
 
19.58%
$127.06M
 
45.50%
Avg: $3.37M
Low: $3.37M
High: $3.37M
avg. -97.34%
Avg: $72.28M
Low: $72.28M
High: $72.28M
avg. 2038.78%
Avg: $890.73M
Low: $890.73M
High: $890.73M
avg. 1132.25%
Avg: $1.37B
Low: $1.37B
High: $1.37B
avg. 53.87%

FAQ

What is RAPT Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 78.54% in 2025-2028.

We have gathered data from 7 analysts. Their low estimate is -190.15M, average is -132.05M and high is -41.40M.

What is RAPT Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 806.22% in 2025-2028.

We have gathered data from 6 analysts. Their low revenue estimate is $768.35K, average is $768.35K and high is $768.35K.

What is RAPT Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 93.08% in 2025-2028.

We have gathered data from 7 analysts. Their low earnings per share estimate is -$4.96, average is -$2.64 and high is $-1.08.

What is the best performing analyst?

In the last twelve months 2 analysts have been covering RAPT Therapeutics stock. The most successful analyst is Alex Thompson.